TY - JOUR
T1 - Stroke and bleeding risk evaluation in atrial fibrillation
T2 - results of the European Heart Rhythm Association survey
AU - Larsen, Torben Bjerregaard
AU - Potpara, Tatjana
AU - Dagres, Nikolaos
AU - Pison, Laurent
AU - Estner, Heidi
AU - Blomström-Lundqvist, Carina
AU - Scientific Initiative Committee, European Heart Rhythm Association
PY - 2014/5
Y1 - 2014/5
N2 - The aim of this European Heart Rhythm Association (EHRA) survey was to assess clinical practice in relation to stroke and bleeding risk evaluation in atrial fibrillation, particularly regarding the use of risk evaluation schemes, among members of the EHRA electrophysiology (EP) research network. In this EP Wire survey, we have provided some insights into current practice in Europe for the use of these risk assessment schemes. There were some obvious practice differences. However, reassuring information on current practice in Europe was evident, but more focus on renal function is warranted, especially facing the fact that novel oral anticoagulants are used for antithrombotic therapy.
AB - The aim of this European Heart Rhythm Association (EHRA) survey was to assess clinical practice in relation to stroke and bleeding risk evaluation in atrial fibrillation, particularly regarding the use of risk evaluation schemes, among members of the EHRA electrophysiology (EP) research network. In this EP Wire survey, we have provided some insights into current practice in Europe for the use of these risk assessment schemes. There were some obvious practice differences. However, reassuring information on current practice in Europe was evident, but more focus on renal function is warranted, especially facing the fact that novel oral anticoagulants are used for antithrombotic therapy.
U2 - 10.1093/europace/euu089
DO - 10.1093/europace/euu089
M3 - Journal article
C2 - 24798958
SN - 1099-5129
VL - 16
SP - 698
EP - 702
JO - Europace
JF - Europace
IS - 5
ER -